Insider Purchase.
Max Link, the chairman of CTIC's board, bought 5000 shares in the open market at a share price of 5,20 on March 10. This brought his total holding to 73,572 shares.
Was this an act of support, greed or defiance in the face of adverse market conditions? I would really like to know.
Erik
Max Link, Ph.D.
Chairman of the Board of Directors, Former Chairman and CEO, Centerpulse, Ltd.
Director Since 7/1/1995
Max Link, Ph.D., joined the Board of Directors in July 1995 as its Vice-Chairman and has served as Chairman of the Board of Directors since January 1996. In addition, Dr. Link has held a number of executive positions with pharmaceutical and healthcare companies. Most recently, he served as Chief Executive Officer of Corange, Limited, ("Corange") from May 1993 until June 1994. Prior to joining Corange, Dr. Link served in a number of positions within Sandoz Pharma Ltd., including Chief Executive Officer from 1990 until April 1992, and Chairman from April 1992 until May 1993. Dr. Link currently serves on the boards of directors of Alexion Pharmaceuticals, Inc., Human Genome Sciences, Inc., Procept, Inc. and Protein Design Labs, Inc. Dr. Link received his Ph.D. in Economics from the University of St. Gallen.
|
